Key stats
About L&G Healthcare Technology & Innovation UCITS ETF Accum Shs USD
Home page
Inception date
Jun 17, 2019
Structure
Irish VCIC
Replication method
Physical
Dividend treatment
Capitalizes
Primary advisor
LGIM Managers (Europe) Ltd.
ISIN
IE00BK5BC677
The L&G Healthcare Breakthrough UCITS ETF (the ETF) aims to track the performance of the ROBO Global Healthcare Technology and Innovation Index TR (the Index).
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.09%
Health Technology80.18%
Technology Services5.36%
Commercial Services4.70%
Health Services4.00%
Distribution Services1.72%
Electronic Technology1.56%
Bonds, Cash & Other1.91%
Cash2.50%
Miscellaneous−0.59%
Stock breakdown by region
North America79.89%
Europe15.95%
Asia4.16%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
DOCT invests in stocks. The fund's major sectors are Health Technology, with 80.65% stocks, and Technology Services, with 5.39% of the basket. The assets are mostly located in the North America region.
DOCT assets under management is 80.16 M EUR. It's fallen 0.64% over the last month.
DOCT fund flows account for 16.65 M EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, DOCT doesn't pay dividends to its holders.
DOCT shares are issued by Legal & General Group Plc under the brand L&G. The ETF was launched on Jun 17, 2019, and its management style is Passive.
DOCT expense ratio is 0.49% meaning you'd have to pay 0.49% of your investment to help manage the fund.
DOCT follows the ROBO Global Healthcare Technology and Innovation ETF. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
DOCT invests in stocks.
DOCT price has risen by 1.41% over the last month, and its yearly performance shows a 1.05% increase. See more dynamics on DOCT price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −0.33% over the last month, have fallen by −0.33% over the last month, showed a 10.21% increase in three-month performance and has decreased by −0.17% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −0.33% over the last month, have fallen by −0.33% over the last month, showed a 10.21% increase in three-month performance and has decreased by −0.17% in a year.
DOCT trades at a premium (0.19%) meaning the ETF is trading at a higher price than the calculated NAV.